• Home
  1. Home
  2. Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
Scientific article
OA Policy
English

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists

ContributorsFinckh, Axelorcid; Möller, Burkhard; Dudler, Jean; Walker, Ulrich A; Kyburz, Diego; Gabay, Cem
Published inAnnals of the rheumatic diseases, vol. 71, no. 10, p. 1680-1685
Publication date2012
Abstract

Observational studies have suggested that patients with rheumatoid arthritis (RA) who experience inadequate response to anti-tumour necrosis factor (anti-TNF) agents respond more favourably to rituximab (RTX) than to an alternative anti-TNF agent. However, the relative effectiveness of these agents on long-term outcomes, particularly in radiographic damage, remains unclear.

Keywords
  • Antirheumatic Agents/therapeutic use
  • Arthritis, Rheumatoid/drug therapy/radiography
  • Cohort Studies
  • Humans
  • Joints/pathology
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors
Affiliation entities
Research groups
Citation (ISO format)
FINCKH, Axel et al. Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. In: Annals of the rheumatic diseases, 2012, vol. 71, n° 10, p. 1680–1685. doi: 10.1136/annrheumdis-2011-201016
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN0003-4967
570views
441downloads

Technical informations

Creation15/11/2013 16:19:00
First validation15/11/2013 16:19:00
Update24/01/2025 14:38:35
Status update24/01/2025 14:38:35
Last indexation24/01/2025 14:45:53
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack